Enomark Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.20 M
as on 24-10-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 24-10-2024
- Satisfied Charges ₹ 1.62 M
as on 24-10-2024
- Revenue -26.53%
(FY 2023)
- Profit 917.33%
(FY 2023)
- Ebitda -6.65%
(FY 2023)
- Net Worth 126.03%
(FY 2023)
- Total Assets 56.25%
(FY 2023)
About Enomark Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹1.62 M, as per Ministry of Corporate Affairs (MCA) records.
Mangalaram Choudhary and Sohan Patel serve as directors at the Company.
- CIN/LLPIN
U24304GJ2017PTC098341
- Company No.
098341
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Enomark Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mangalaram Choudhary  | Director | 19-Jul-2017 | Current |
| Sohan Patel | Director | 19-Jul-2017 | Current |
Financial Performance of Enomark Healthcare.
Enomark Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.53% decrease. The company also saw a substantial improvement in profitability, with a 917.33% increase in profit. The company's net worth Soared by an impressive increase of 126.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enomark Healthcare?
In 2022, Enomark Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jun 2024 | ₹5.00 M | Open |
Canara Bank Creation Date: 12 Jun 2018 | ₹0.50 M | Satisfied |
Canara Bank Creation Date: 16 Nov 2017 | ₹1.12 M | Satisfied |
How Many Employees Work at Enomark Healthcare?
Enomark Healthcare has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enomark Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enomark Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
